Plain-English translation of NCT06873555 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Solid Tumors research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help treat advanced cancers, particularly ovarian cancer and small cell lung cancer that have come back or stopped responding to standard chemotherapy. The study is divided into two parts: the first part will confirm the right dose and test how well and safely the medication works in different cancer types; the second part will expand testing based on what the researchers learn.
Many patients with advanced ovarian cancer and other solid tumors run out of effective treatment options when their cancer becomes resistant to standard chemotherapy. This trial is exploring whether this new medication could offer hope to people whose cancers are no longer responding to conventional treatments.
You likely qualify if…
You likely don't qualify if…
If you are accepted into the trial, you will take the medication by mouth once every day, continuously, in 4-week treatment cycles. The study will monitor how well the medication works, check for side effects, and measure how your body processes the drug through regular visits and blood tests. Depending on which part of the trial you join, you may be one of the first 40 participants helping to confirm the safest and most effective dose, or one of 20 additional participants in the later phase of testing.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China